| Contraception |
1 |
1 |
| Transdermal |
0 |
0.73 |
| Pregnancy |
0 |
0.5 |
| Estrogen |
0 |
0.42 |
| Health Care Reform |
0 |
0.42 |
| Revenue and Practice Management |
0 |
0.38 |
| Sterilization, Birth Control |
0 |
0.34 |
| Birth |
0 |
0.24 |
| Insurance |
0 |
0.24 |
| Health Insurance |
0 |
0.21 |
| Thromboembolism |
0 |
0.19 |
| Generics |
0 |
0.18 |
| Food and Drug Administration (FDA) |
0 |
0.16 |
| Affordable Care Act |
0 |
0.12 |
| Progestin |
0 |
0.12 |
| Venous Thromboembolism (VTE) |
0 |
0.1 |
| Breast |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Gastrointestinal Disease |
0 |
0.06 |
| Hemorrhage |
0 |
0.06 |
| Hormonal Contraception |
0 |
0.06 |
| Vagina |
0 |
0.06 |
| Xeroderma |
0 |
0.06 |